On March 27, 2024, Ann & Robert H. Lurie Children’s Hospital of Chicago treated its first patient with ELEVIDYS (delandistrogene moxeparvovec-rokl), the first gene therapy for Duchenne muscular dystrophy – a rare, genetic disease characterized by progressive muscle damage and weakness.
J&J’s Aldo Denti on digital technology in orthopedics
Johnson & Johnson’s orthopedics unit is undergoing several changes as it looks to enter high-growth markets. Last year, J&J announced the unit would exit less
March 29, 2024